Global News

[ad_1] Decreased appetite, also known as poor appetite or loss of appetite, refers to a reduced desire to eat. The medical term for this is anorexia. Various mental and physical health issues can lead to decreased appetite, which may be accompanied by symptoms like weight loss or malnutrition. If not treated, these symptoms can pose serious health risks. Therefore, it's important to identify the underlying cause of decreased appetite and address it promptly. Dr Manoharan B, Senior Consultant – Nephrology, Manipal Hospital Varthur Road & Whitefield, Bengaluru shares how a decreased appetite can be indictive of early signs of kidney damage and diseases. Symptoms of Decreased Appetite Several conditions can cause decreased appetite. Typically, once the underlying condition is treated, appetite tends to return to normal. However, if left untreated, decreased appetite can lead to more severe symptoms given by Dr Manoharan: - extreme fatigue - weight loss - a rap

[ad_1] Pregnancy-related obesity brings with it complicated issues that demand extensive understanding and preventive care. It is critical to highlight the complex concerns that obesity in mothers poses to both the growing fetus and the expecting mother. The implications of maternal obesity extend beyond pregnancy, impacting the long-term health of both the mother and child. Understanding these complexities is crucial for effective intervention and management. According to the WHO, more than 1 billion people globally are suffering from obesity – 650 million adults, 340 million youth, and 39 million children. In a place where more than one-third of the population is obese, highlighting the adverse effects of this epidemic is of immense importance. How Obesity Affects Female Reproductive Health Dr Garima Sawhney, Senior Gynaecologist and Co-founder, Pristyn Care shares, "Maternal obesity increases the likelihood of experiencing a few issues throughout pregnancy. The prim

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters Drugmakers aren't the only ones feeling the impact of the weight loss industry gold rush.  Retailers with pharmacy businesses, such as Walmart , Kroger and Rite Aid , said increased demand for prescription weight loss drugs helped boost sales for the second quarter.  But analysts note that those blockbuster treatments are minimally profitable for retail pharmacies – and may even come with margin headwinds. "More recently, you're starting to hear retailers talk about these drugs. But I wouldn't say they're necessarily beneficiaries of the increased popularity," Arun Sundaram, an analyst at CFRA Research, told CNBC. "They're really not making much of a profit on the drugs. So it's really just a traffic driver and not really a p

[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker , for up to $1.93 billion to boost the pharmaceutical giant's weight loss treatment portfolio.  Eli Lilly agreed to pay Versanis shareholders in cash, which will consist of an upfront payment and potentially subsequent payments if Versanis achieves certain "development and sales milestones." Oakland, California-based Versanis, which was founded in 2021 by biotech investment firm Aditum Bio, has one experimental drug for obesity and potentially other conditions. Eli Lilly's stock price rose 3% on Friday following the announcement. The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which began last year after Novo Nordisk' s blockbuster injections Wegovy and Ozempic boomed in popularity.  An est